Mark Stultz Email & Phone Number

From a wonderful 30+ year career as a medical device executive to founder of a children's products company! HiddenHelper is a patented product that all 9 of my grandchildren have enjoyed that is finally available to everyone. As you will see when you look at the listing on Amazon, or on our website at www.myhiddenhelper.com this is a stool that fosters.

Cleveland, Ohio, US

• Provide market development leadership to SPR Therapeutics and the NDI enterprise related to market opportunity assessment, message, value story and business plan creation, refinement and validation, clinical trial.
• Develop the integrated message and value story across indications and among multiple stakeholders to include patients, physicians, hospitals, payers, investors and corporate strategics
• Assess opportunities for indication and geography-specific expansion
• Conduct market research to refine message and focus company on prioritized high-value opportunities
• Identify high-potential clinical and commercialization partners and develop key opinion leading physicians and surgeons across multiple specialties within pain, regional anesthesia, orthopedic surgery, and physical.
• Lead the accelerated clinical trial recruitment efforts for four in-process clinical trials

• I formed MDMD, LLC after identifying a need among start-up medical device and life science clients who need senior level market development support beyond that which the current senior management team is able to.
• EU market assessment and management of reimbursement process and launch strategy
• Start-up due diligence and business planning
• Identification and vetting of potential KOL advocates
• Market research identifying unbiased insights from physicians, patients and other health care system professionals
• Positioning or position refinement for fundraising or launch

Shoreview, Minnesota, US

• Selected as part of a national retained search to lead market development efforts as the company pursues European commercialization. Torax’s implantable device is intended to fill the therapeutic gap that exists.
• Identified market entry geographies as a function of regulatory clearance, budget access, reimbursement requirements, proximity and the strength of surgeon influence over financial decision-making within the markets..
• Sourced geography-specific reimbursement counsel to initiate the processes of gaining access to reimbursement funds and any specialty programs available to usher in new technologies (e.g., NUB, TARMED and Regional.
• Developed a Budget Impact Model in Italy resulting in the approval to implant 60 new devices on an outpatient basis within Lombardia during the first year of launch. The Italian model was parlayed into a rapid HTA in.
• Targeted high-volume centers in Germany to submit NUB applications as part of the strategic market entry process for new technologies that had been adopted by the Germany government. Ten centers agreed to submit.
• Initiated a pan-European post-market registry to monitor and assure continued positive outcomes in carefully selected patients in whom the device was purchased.

Eden Prairie, MN, US

ThreeWire exists to expedite market entry and maximize return on investments within the medical device, biotech and pharmaceutical space. The sweet spot within our offering involves bringing strategic planning and a systematic process to the enrollment process for pilot, pivotal and other clinical trials where time to completion and time to market are.

San Clemente, CA, US

Santa Clarita, CA, US

Minneapolis, MN, US

Minneapolis, MN, US

Ms, Human Factors Engineering And Ergnomics

Bs, Physical Therapy